FI934665A0 - ARYLIDEN-1-AZACYKLOALKANER OCH ARYLALKYL-1-AZACYCKLOALKANER, DERAS SALTER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH DERAS ANVAENDNING OCH FRAMSTAELLNING - Google Patents

ARYLIDEN-1-AZACYKLOALKANER OCH ARYLALKYL-1-AZACYCKLOALKANER, DERAS SALTER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH DERAS ANVAENDNING OCH FRAMSTAELLNING

Info

Publication number
FI934665A0
FI934665A0 FI934665A FI934665A FI934665A0 FI 934665 A0 FI934665 A0 FI 934665A0 FI 934665 A FI934665 A FI 934665A FI 934665 A FI934665 A FI 934665A FI 934665 A0 FI934665 A0 FI 934665A0
Authority
FI
Finland
Prior art keywords
och
deras
arylalkyl
azacykloalkaner
azacyckloalkaner
Prior art date
Application number
FI934665A
Other languages
Finnish (fi)
Other versions
FI934665A (en
Inventor
Roland Maier
Peter Mueller
Eberhard Woitun
Rudolf Hurnaus
Michael Mark
Bernhard Eisele
Ralph-Michael Budzinski
Gerhard Hallermayer
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4235590A external-priority patent/DE4235590A1/en
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI934665A0 publication Critical patent/FI934665A0/en
Publication of FI934665A publication Critical patent/FI934665A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ink Jet (AREA)
  • Developing Agents For Electrophotography (AREA)

Abstract

The invention relates to arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes of the general formula <IMAGE> in which n, m, p, A, W<1>, W<2>, X, Y and R<1> to R<11> are defined as in Claim 1, their isomers and isomer mixtures and their salts, which have useful properties and in particular exert an inhibitory action on cholesterol biosynthesis.
FI934665A 1992-10-22 1993-10-22 Arylidene-1-azacycloalkaner and arylalkyl-1-azacycloalkaner, for example, in the form of an intermediate and anhydrous and frameworks FI934665A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4235590A DE4235590A1 (en) 1992-10-22 1992-10-22 Arylidene-1-aza:cycloalkane derivs. - are inhibitors of cholesterol biosynthesis and hence useful in treating hyper-cholesterolaemia and atherosclerosis.
DE4303840A DE4303840A1 (en) 1992-10-22 1993-02-10 Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, pharmaceutical compositions containing them and their use, and processes for their preparation

Publications (2)

Publication Number Publication Date
FI934665A0 true FI934665A0 (en) 1993-10-22
FI934665A FI934665A (en) 1994-04-23

Family

ID=25919689

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934665A FI934665A (en) 1992-10-22 1993-10-22 Arylidene-1-azacycloalkaner and arylalkyl-1-azacycloalkaner, for example, in the form of an intermediate and anhydrous and frameworks

Country Status (21)

Country Link
EP (1) EP0596326B1 (en)
JP (1) JP3396517B2 (en)
KR (1) KR100306520B1 (en)
CN (1) CN1040873C (en)
AT (1) ATE126797T1 (en)
AU (1) AU665648B2 (en)
CA (1) CA2108817C (en)
CZ (1) CZ286025B6 (en)
DE (2) DE4303840A1 (en)
DK (1) DK0596326T3 (en)
ES (1) ES2078787T3 (en)
FI (1) FI934665A (en)
GR (1) GR3017692T3 (en)
HK (1) HK1000285A1 (en)
HU (1) HU221630B1 (en)
IL (1) IL107342A (en)
NO (1) NO300843B1 (en)
NZ (1) NZ250018A (en)
PL (1) PL173775B1 (en)
RU (1) RU2126400C1 (en)
SK (1) SK281222B6 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4234295A1 (en) * 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carboxylic acid derivatives, medicaments containing these compounds and process for their preparation
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
DE19754795A1 (en) * 1997-12-10 1999-06-17 Boehringer Ingelheim Pharma New urethanes, their thio and dithio analogues, their salts, medicines containing them and their use, and processes for their preparation
AU5227999A (en) * 1998-07-27 2000-02-21 Abbott Laboratories Substituted oxazolines as antiproliferative agents
US6228868B1 (en) 1998-07-27 2001-05-08 Abbott Laboratories Oxazoline antiproliferative agents
EP1499306A4 (en) 2002-04-12 2007-03-28 Merck & Co Inc Bicyclic amides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863932A (en) * 1988-03-11 1989-09-05 Somatogenetics International, Inc. Squalene oxide cyclase inhibitors and therapeutic use thereof
CA2025490C (en) * 1989-09-22 2003-09-16 James R. Mccarthy Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
CA2047375C (en) * 1990-07-25 2003-04-15 Charlotte L. Barney Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
US5084461A (en) * 1991-03-27 1992-01-28 Merrell Dow Pharmaceuticals Inc. Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis

Also Published As

Publication number Publication date
PL300834A1 (en) 1994-05-16
CA2108817C (en) 2004-12-07
DK0596326T3 (en) 1996-01-15
HU9302986D0 (en) 1994-01-28
RU2126400C1 (en) 1999-02-20
PL173775B1 (en) 1998-04-30
AU4913593A (en) 1994-05-05
KR940009181A (en) 1994-05-20
CZ223693A3 (en) 1994-05-18
NO933790D0 (en) 1993-10-21
NZ250018A (en) 1995-07-26
CZ286025B6 (en) 1999-12-15
JP3396517B2 (en) 2003-04-14
ATE126797T1 (en) 1995-09-15
IL107342A (en) 1997-07-13
DE4303840A1 (en) 1994-08-11
AU665648B2 (en) 1996-01-11
EP0596326B1 (en) 1995-08-23
HK1000285A1 (en) 1998-02-20
NO933790L (en) 1994-04-25
HU221630B1 (en) 2002-12-28
ES2078787T3 (en) 1995-12-16
DE59300507D1 (en) 1995-09-28
CN1090849A (en) 1994-08-17
SK107393A3 (en) 1994-09-07
KR100306520B1 (en) 2001-11-30
FI934665A (en) 1994-04-23
GR3017692T3 (en) 1996-01-31
EP0596326A1 (en) 1994-05-11
IL107342A0 (en) 1994-01-25
HUT68958A (en) 1995-08-28
NO300843B1 (en) 1997-08-04
SK281222B6 (en) 2001-01-18
CA2108817A1 (en) 1994-04-23
CN1040873C (en) 1998-11-25
JPH06192256A (en) 1994-07-12

Similar Documents

Publication Publication Date Title
NO912630L (en) PROCEDURE FOR THE PREPARATION OF NEW 2,6-DIALKYL-4-SILYL-PHENOLES AS ANTI-AARTHERIOSCLEROTIC AGENTS
DK0618190T3 (en) 9- (Substituted glycyl) amido-6- (substituted) -5-hydroxy-6-deoxy-tetracyclines
ATE168992T1 (en) 7-SUBSTITUTED-9-SUBSTITUTED GLYCYLAMIDO-6-DEMETHYL-6-DEOXYTETRACYCLINE
FI933568A (en) 9 - ((substituted glycyl) amido) -6-demethyl-6-deoxytetracycline
ES2081120T3 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF BACATINE III AND DESACETIL-10 BACATINE III.
ES2193241T3 (en) NEW N-2-OXO2.3.4.5-TETRAJODRP-1H-1,5-BENZODIAZEPIN-3-IL) -3-AMIDAS.
ATE144498T1 (en) PREPARATION OF SUBSTITUTED PIPERIDINES
FI934665A0 (en) ARYLIDEN-1-AZACYKLOALKANER OCH ARYLALKYL-1-AZACYCKLOALKANER, DERAS SALTER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH DERAS ANVAENDNING OCH FRAMSTAELLNING
DK0623620T3 (en) 5-HT 3 pyrrolopyrazinderivater
NO954805D0 (en) Anxiolytic agent
ES2150479T3 (en) DERIVATIVES OF PSICOFURANOSA AND PSICOPIRANOSA.
DE69116057D1 (en) Microbial production of the 13-beta-13-deoxy-22,23, -dihydroavermectin-Bla / B1b aglycone
NO921706D0 (en) NEW 2-BRAND CAPTOMETHYLENE-TETRAHYDRONE AFHALENE AND INDANE-2-CARBOXAMIDE DERIVATIVES AS ENCYPHALINASE INHIBITORS
NO960271L (en) Thiocarbamoyl compounds used as microbiocides
EP0751130A4 (en) 4,5-dihydropyrazole-5-thione derivatives and acaricide containing the same
FI946009A0 (en) Use of anti-staining agents in the manufacture of isocyanate-based foams